FDA Approves HPV Vaccine Gardasil As Throat Cancer Prevention
The HPV vaccine (Gardasil 9) has been approved by the Food and Drug Administration (FDA) for males and females ages 9 to 45 years to prevent HPV-related genital tract and anogenital infections and cancers for several years.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer Vaccine | Food and Drug Administration (FDA) | Gardasil | Pharmaceuticals | Vaccines